Product Categories
| Country: | United States |
|---|---|
| Tel: | +86-0714-3992388 |
| Mobile: | +86-15391658522 |
| E-mail: | overseasales@yongstandards.com |
| QQ: | 2853117752 |
| Skype: | Chat Now! |
| Address: | No.176,Hangzhou West Road, Xialu Area, Huangshi |
|
China National Standard Pharmaceutical Corporation Limited is a strict standard company. Its main members are former senior employees from EDQM and The United States Pharmacopeial Convention. Standardpharm Co., Ltd. work together with Standardpharm CHN Co., Ltd. to serve scientists in the field of generic pharmaceuticals and innovative pharmaceuticals worldwide.
Standardpharm Co., Ltd. is a professional company specializing in the custom synthesis of pharmaceutical reference standards for biomedical and pharmaceutical research. We supply reference standards worldwide to clients base that includes major biotechnology corporations, pharmaceutical and diagnostic companies, clinical and bio-analytical CROs, manufacturers of specialty chemicals, as well as hospital researchers, universities and various other research institutions, including EDQM, USP, BP, JP, CHP, and Pfizer, TEVA, etc.
Standardpharm has over 600,000 products in 10 application area, including: Pharmaceutical Impurities, Pesticide and Veterinary Pharmaceutical Residues, Isotopes, Essence and Pigment, Criminal Justice Medicine, Natural pharmaceutical Extraction, Cosmetic, Environmental Protection, Food safety, Industrial Auxiliary Materials. Certificate of Analysis (COA) will be provided for all these products which characterized using HPLC/GC, MS, HNMR, synthetic route, spectrum analysis and other testing (CNMR, FNMR, COSY, NOESY, DEPT, HMBC, HMQC, HSQC, IR, UV, QNMR, TGA, elemental analysis, etc. ) as requested spectra by our clients. And STD Promises to return or exchange the goods to solve the problem as quickly as possible if any quality problem is found within the contractual period. STD has inventory in both China and the United States to ensure the fastest delivery for customers.
Welcome to consult us by email in any time.
|
|
| Product Name | MF | CAS | Details |
|---|
| Brexpiprazole Impurity 7 | C13H15NO3 | 1886188-97-1 | Details |
| Brexpiprazole Impurity 4 | C9H7NO2 | 70500-72-0 | Details |
| Brexpiprazole Impurity 41 | C16H15NO2 | 15116-41-3 | Details |
| Brexpiprazole Impurity 49 | C13H14N2O2S | 1700655-67-9 | Details |
| Brexpiprazole Impurity 54 | C8H2Cl2N2O2 | 4640-41-9 | Details |
| Brexpiprazole Impurity 58 | C26H27ClN2O4 | 2247155-47-9 | Details |
| Brexpiprazole Impurity 6 | C16H22N2OS | 913614-15-0 | Details |
| Brexpiprazole Impurity 70 | C9H9NO2 | 30389-33-4 | Details |
| Brexpiprazole Impurity 71 | C9H9NO2 | 52749-50-5 | Details |
| Brexpiprazole Impurity 72 | C9H9NO2 | 54197-66-9 | Details |
| Brexpiprazole Impurity 73 | C7H9NO | 536-90-3 | Details |
| Brexpiprazole Impurity 74 | C12H14N2O | 105685-34-5 | Details |
| Brexpiprazole Impurity 75 | C38H41IN4O4S | 2454317-19-0 | Details |
| Brexpiprazole Impurity 75 Chloride | C38H41ClN4O4S | 2454317-17-8 | Details |
| Brexpiprazole Impurity 76 | C12H14N2S | 433303-94-7 | Details |
| Brexpiprazole Impurity 77 | C12H14N2S | 1783311-11-4 | Details |
| Brexpiprazole Impurity 78 | C12H14N2S | 105685-06-1 | Details |
| Bosentan Impurity 10(Bosentan USP Related Compound A) | C25H24ClN5O4S | 150727-06-3 | Details |
| Bortezomib Impurity 9 | C19H25BN4O4 | 1132709-14-8 | Details |
| Bortezomib Impurity 8 | C19H25BN4O4 | 1132709-16-0 | Details |
| Bortezomib Impurity 7 | C19H25BN4O4 | 1132709-15-9 | Details |
| Bortezomib Impurity 68 | C28H34BN5O6 | 1194235-43-2 | Details |
| Bortezomib Impurity 6 | C14H13N3O3 | 114457-94-2 | Details |
| Bortezomib Impurity 54 | C14H19NO4 | 13734-34-4 | Details |
| Bortezomib Impurity 58 | C14H20BNO6 | 111771-57-4 | Details |
| Brexpiprazole Impurity 106 | C17H23Cl2NO2 | 2295935-56-5 | Details |
| Bortezomib Impurity 53 | C14H19NO4 | 18942-49-9 | Details |
| Bortezomib Impurity 41 | C11H25BClNO2 | 2493017-06-2 | Details |
| Bortezomib Impurity 5 | C19H24N4O4 | 886979-81-3 | Details |
| Brexpiprazole Impurity 11 | C25H27N3O3S | 1191900-58-9 | Details |
| Brexpiprazole Impurity 113 | C17H22N2O2S | 1191901-07-1 | Details |
| Brexpiprazole Impurity 114 | C17H21Br2NO2 | 1076199-56-8 | Details |
| Brexpiprazole Impurity 115 | C17H21BrClNO2 | 2247155-45-7 | Details |
| Brexpiprazole Impurity 116 | C17H21BrClNO2 | 2247155-44-6 | Details |
| Brexpiprazole Impurity 117 | C17H21BrClNO2 | 2247155-43-5 | Details |
| Brexpiprazole Impurity 13 | C25H27N3O4S | 2247155-42-4 | Details |
| Brexpiprazole Impurity 15 | C38H40N4O4S | 2094559-58-5 | Details |
| Brexpiprazole Impurity 17 | C20H20N2S2 | 1420987-85-4 | Details |
| Brexpiprazole Impurity 18 | C17H21Cl2NO2 | 2059954-32-2 | Details |
| Brexpiprazole Impurity 2 | C12H15ClN2S | 913614-18-3 | Details |
| Brexpiprazole Impurity 24 | C26H27ClN2O4 | 2060029-80-1 | Details |
| Brexpiprazole Impurity 26 | C13H14BrNO2 | 203395-59-9 | Details |
| Brexpiprazole Impurity 27 | C9H7NO2 | 31570-97-5 | Details |
| Brexpiprazole Impurity 29 | C15H13NO2 | 23478-25-3 | Details |
| Brexpiprazole Impurity 3 | C20H18N2S2 | 1420987-86-5 | Details |
| Brexpiprazole Impurity 30 | C17H21Cl2NO2 | 2060027-95-2 | Details |
| Brexpiprazole Impurity 31 | C38H40N4O4S | 2116542-21-1 | Details |
| Brexpiprazole Impurity 32 | C16H21BrN2S | 2143944-65-2 | Details |
| Brexpiprazole Impurity 32 Chloride | C16H21ClN2S | 2760672-16-8 | Details |
| Brexpiprazole Impurity 33 | C41H47N5O2S2 | 2138169-93-2 | Details |
| Bosentan Impurity 11(Bosentan USP Related Compound D) | C15H10Cl2N4O2 | 150728-13-5 | Details |
| Bosutinib Impurity 4 | C18H13Cl2N3O3 | 1460227-29-5 | Details |
| Bosutinib Impurity 24 | C20H15NO2 | 51334-77-1 | Details |
| Bosutinib Impurity 2 | C25H27Cl2N5O3 | 380843-81-2 | Details |
| Bosutinib Impurity 17 | C26H31Cl2N5O4 | 2468737-90-6 | Details |
| Bosutinib Impurity 15 | C7H16N2O | 4128-37-4 | Details |
| Bosutinib Impurity 11 | C7H14N2 | 693-13-0 | Details |
| Bosentan Impurity 6 | C52H52N10O10S2 | 1097263-60-9 | Details |
| Bosentan Impurity 3 | C26H27N5O7S | 253688-62-9 | Details |
| Bosentan Impurity 4 | C26H27N5O6S | 253688-61-8 | Details |
| Bosentan Impurity 5 | C25H25N5O5S | 174227-14-6 | Details |
| Bosentan Impurity 8 | C10H14O3S | 1133-17-1 | Details |
| Bosentan Impurity 2(Hydroxy Bosentan) | C27H29N5O7S | 253688-60-7 | Details |
| Bosentan Impurity 15 | C31H37N5O6S | 301646-60-6 | Details |
| Bosentan Impurity 14 | C28H29N5O7S | 301646-61-7 | Details |
| Bosentan Impurity 12(Bosentan USP Related Compound E) | C10H15NO2S | 6292-59-7 | Details |
| Bosutinib Impurity 5 | C26H29Cl2N5O3 | 1391063-17-4 | Details |
| Brassicasterol Impurity 4 | C10H20 | 19780-60-0 | Details |
| Brassicasterol Impurity 5 | C10H20 | 86869-76-3 | Details |
| Brassicasterol Impurity 6 | C10H20 | 62338-08-3 | Details |
| Brassicasterol Impurity 7 | C10H20 | 19780-61-1 | Details |
| Brassicasterol Impurity 8 | C10H20 | 53966-51-1 | Details |
| Brassicasterol Impurity 9 | C8H16 | 7423-69-0 | Details |
| Brexanolone Impurity 3 | C22H36O2 | 1264737-31-6 | Details |
| Brexpiprazole Impurity 1 | C8H5BrS | 5118-13-8 | Details |
| Brexpiprazole Impurity 10 | C25H29N3O2S | 913612-07-4 | Details |
| Bortezomib Impurity 23 | C15H26BClO2 | 85167-14-2 | Details |
| Bortezomib Impurity 25 | C15H29BClNO2 | 945606-99-5 | Details |
| Bortezomib Impurity 26 | C10H18O2 | 18680-27-8 | Details |
| Bortezomib Impurity 27 | C19H24N4O2 | 1446194-56-4 | Details |
| Bortezomib Impurity 28 | C19H22N4O3 | 862894-96-0 | Details |
| Bortezomib Impurity 3 | C14H14N4O2 | 289472-80-6 | Details |
| Bortezomib Impurity 30 | C28H34BN5O5 | 1194235-41-0 | Details |
| Bortezomib Impurity 38 | C57H69B3N12O9 | 390800-88-1 | Details |
| Bortezomib Impurity 4 | C19H24N4O4 | 886979-78-8 | Details |
| Bortezomib Impurity 40 | C14H23BN2O3 | 948294-96-0 | Details |
| Blonanserin Impurity 21 | C23H30FN3O | 142838-82-2 | Details |
| Blonanserin Impurity 28 | C17H17ClFN | 132813-14-0 | Details |
| Blonanserin Impurity 29 | C17H18FNO | 132812-72-7 | Details |
| Blonanserin Impurity 3 | C21H26FN3 | 132811-84-8 | Details |
| Blonanserin Impurity 30 | C6H14N2 | 5308-25-8 | Details |
| Blonanserin Impurity 31 | C24H33N3O | 132810-93-6 | Details |
| Blonanserin Impurity 32 | C6H13N3O | 65504-33-8 | Details |
| Bortezomib Impurity 1 | C19H24N4O3 | 289472-78-2 | Details |
| Bortezomib Impurity 13 | C14H13N3O3 | 1608986-16-8 | Details |
| Bortezomib Impurity 16 | C19H22N4O2 | 862895-00-9 | Details |
| Bortezomib Impurity 17 | C19H22N4O4 | 2379402-85-2 | Details |
| Bortezomib Impurity 2 | C19H24N4O3 | 289472-81-7 | Details |
| Brexpiprazole Impurity 105 | C12H14N2O2S | 1191900-95-4 | Details |
| Brexpiprazole Impurity 104 | C9H9NO2 | 120410-28-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 | ||||